Anorexia in Adolescence Clinical Trial
— HTEDOfficial title:
Evaluation of the Effectiveness of Add-on Hometreatment to Family Based Therapy in Adolescent Anorexia Nervosa. A Randomised Controlled Clinical Trial
Verified date | June 2022 |
Source | Psychiatric University Hospital, Zurich |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The project serves to evaluate a new treatment method with outreach services as a supplement to family-based therapy in the treatment of children and adolescents with eating disorders. The project is intended to help identify different family structures and which families will benefit most from the new outreach service of home-based treatment.
Status | Recruiting |
Enrollment | 90 |
Est. completion date | December 31, 2024 |
Est. primary completion date | December 31, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 12 Years to 20 Years |
Eligibility | Inclusion Criteria: - Children and adolescents aged 12 -20 years. - Successful registrations in the special consultation for eating disorders at the Clinic for Child and Adolescent Psychiatry and Psychotherapy (KJPP) of the Psychiatric University Hospital (PUK) Zurich. - Diagnosis of anorexia nervosa or atypical anorexia nervosa (ICD-10 F50.00/ F50.01/ F50.1) - Existing informed consent of patients* (14 years and older) and parents or legal guardians (12-14 years). - IQ over 75 - Resident in the canton of Zurich - Good knowledge of German Exclusion Criteria: - No written consent - Children under 12 years - Other forms of eating disorders apart from anorexia nervosa or atypical anorexia nervosa. |
Country | Name | City | State |
---|---|---|---|
Switzerland | Psychiatrische Universitätsklilnik Zürich | Zürich |
Lead Sponsor | Collaborator |
---|---|
Psychiatric University Hospital, Zurich |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Symptomatic improvement | Change of the reported BMI; Weight in Kg and Height in cm will be combined to report BMI in kg/m^2 | 3 months | |
Primary | Symptomatic improvement | Change of the Eating Disorder Examination Interview (EDE) total score analyze using a linear random coefficient regressions model | 3 months | |
Primary | Symptomatic improvement | Change of the Eating Disorder Inventory (EDI) total score analyze using a linear random coefficient regressions model | 3 months | |
Secondary | State of health improvement | Change of the Perceived stress scale (PSS) total score measering level of perceived stress and change of the total score in Brief dyadic scale of expressed emotion (BDSEE) measering level of expressed emotion. | 3 months | |
Secondary | Remission rate | Remission is definde as a Body weight within 15% deviation of the normal weight and clinically unremarkable values in the EDE and EDI | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06244576 -
Emotional Dysregulation, Maladaptive Overcontrol in Anorexia - Effect of Radically Open Dialectical Behaviour Therapy
|
N/A | |
Completed |
NCT03097874 -
Adaptive Treatment for Adolescent Anorexia Nervosa
|
N/A | |
Recruiting |
NCT05057000 -
Effect of Aerobic Exercises and Nutrition In Adolescent Girls With Anorexia
|
N/A | |
Recruiting |
NCT05674266 -
New Treatment Perspectives in Adolescents With Anorexia Nervosa: the Efficacy of Non-invasive Brain-directed Treatment
|
N/A | |
Recruiting |
NCT06097247 -
Family Functioning and Adverse Side Effects of Family-based Therapy for Anorexia Nervosa
|
||
Recruiting |
NCT05235867 -
Secretin in Refeeding
|
||
Not yet recruiting |
NCT05249140 -
Finding Treatments for Eating Disorders
|
N/A | |
Terminated |
NCT05073679 -
Oral Naltrexone In Pediatric Eating Disorders
|
Phase 2/Phase 3 |